The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis

Table 1

Study baseline information was included.

Authors (year)	Stage	Intervention	Sampling	Age (year)	Diabetic duration	DR duration	Jadad scale	Follow-up
Sun et al. (2020)	Proliferative	0.1 ml conbercept + PRP	44	57.94 ± 8.87	8.39 ± 1.32	2.25 ± 0.40	3	1 month, 4 months
		PRP: 4-5 times, every other week	44	58.36 ± 8.49	8.47 ± 1.29	2.20 ± 0.41
Zhang et al. (2020)	Proliferative	0.05 ml conbercept + PRP	24	58.63 ± 5.14	10.32 ± 1.27		3	1 month, 3 months
		PRP: 3-4 times, every other week	25	58.47 ± 5.10	10.42 ± 1.33
Duan et al. (2020)	Proliferative	0.05 ml conbercept + PRP	100	62.3 ± 1.2	6.8 ± 1.0		3	1 month
		PRP: 3-4 times, every other week	100	60.0 ± 2.4	6.2 ± 1.2
Liu et al. (2020)	Nonproliferative and proliferative	0.05 ml conbercept + PRP	56	56.27 ± 3.16			5	1 month
		PRP	56	57.86 ± 3.87
Cui et al. (2019)	Proliferative	0.05 ml conbercept + PRP	32	57.2 ± 9.2	8.4 ± 3.9		5	1 month
		PRP: 3-4 times, every other week	32	59.0 ± 8.0	7.8 ± 4.5
Ye et al. (2019)	Proliferative	0.05 ml conbercept + PRP	50	66.05 ± 10.23			5	3 months
		PRP: 3-4 times, every other week	50	65.84 ± 10.45
Zeng et al. (2018)	Not applicable	0.05 ml conbercept + PRP	40	61.86 ± 12.77	7.61 ± 1.37		5	1 month
		PRP: 500–800 points per time, every other week	40	61.59 ± 12.82	7.57 ± 1.29
Liu et al. (2019)	Nonproliferative	0.1 ml conbercept + PRP	48	58.34 ± 8.47	8.45 ± 1.27	2.18 ± 0.39	5	1 month
		PRP: 4 times, every other week	47	57.92 ± 8.85	8.37 ± 1.30	2.23 ± 0.38
Zhang et al. (2018)	Not applicable	0.1 ml conbercept + PRP	31	50 ± 5	6 ± 3		4	3 months
		PRP: 500–800 points per time, every other 5d	31	49 ± 6	7 ± 3

Note. DR, diabetic retinopathy; PRP, panretinal photocoagulation.